Diabetic Neuropathies: Update on Definitions, Diagnostic Criteria, Estimation of Severity, and Treatments
Open accessThe DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.
Abstract
Preceding the joint meeting of the 19th annual Diabetic Neuropathy Study Group of the European Association for the Study of Diabetes (NEURODIAB) and the 8th International Symposium on Diabetic Neuropathy in Toronto, Canada, 13–18 October 2009, expert panels were convened to provide updates on classification, definitions, diagnostic criteria, and treatments of diabetic peripheral neuropathies (DPNs), autonomic neuropathy, painful DPNs, and structural alterations in DPNs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Prediabetes has been found to be associated with decreased heart rate variability61 (HRV – a marker of parasympathetic function),62–65, decreased postural changes in heart rate,62 increased prevalence of erectile dysfunction among men,66 and a worse profile in tests of sympathetic and parasympathetic function.67”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Studies in prediabetes and sensorimotor neuropathy 68–70 suggest that IGT and early diabetic neuropathy may involve small demyelinated fibres.61”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Diabetic neuropathy (distal symmetric polyneuropathy (DSPN)) causes bilateral decrease or loss of ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“These criteria include obvious bilateral loss or reduction of the ATR.”
From The usefulness of deep tendon reflexes in the diagnosis of lumbar spine diseases: a narrative review (2024) · cites this paper as [36]
The cited source says what the claim attributes to it.
In the citing paper
“No consistent evidence is available to suggest that prediabetes is associated with measurements of orthostatic blood pressure changes,63 which is a late marker of diabetic neuropathy,61 or with decreased expiratory-inspiratory ratio or change in heart rate during breathing.63”
From Prediabetes: a high-risk state for diabetes development (2012) · cites this paper as [61]
2 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Treede (2008) · doi:10.1212/01.wnl.0000282763.29778.59 · Cited by 2,746
Boulton, A. J. M., Vinik, A. I., Arezzo, J. C., Bril, V., Feldman, E. L., Freeman, R., Malik, R. A., Maser, R. E., Sosenko, J. M., & Ziegler, D. (2005) · Diabetes Care · doi:10.2337/diacare.28.4.956 · Cited by 1,859
Self-citationDyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482 · cited 3×
“The typical DPN is a chronic, symmetrical, length-dependent sensorimotor polyneuropathy (DSPN) and is thought to be the most common variety (1).”
BackgroundSelf-citationVascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetic cardiovascular autonomic neuropathy
Vinik, A. I., & Ziegler, D. (2007) · Circulation · doi:10.1161/circulationaha.106.634949 · Cited by 1,255 · cited 3×
“Some pathogenetic mechanisms may link CAN to cardiovascular dysfunction and diabetic complications (34).”
BackgroundInfluentialSelf-citationGæde, P., Vedel, P., Parving, H.-H., & Pedersen, O. (1999) · The Lancet · doi:10.1016/s0140-6736(98)07368-1 · Cited by 981
A systematic review of antidepressants in neuropathic pain
McQuay, H. J., Tramér, M., Nye, B. A., Carroll, D., Wiffen, P. J., & Moore, R. A. (1996) · Pain · doi:10.1016/s0304-3959(96)03140-5 · Cited by 930
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913 · cited 3×
“The symptoms are distal, symmetrical, often associated with nocturnal exacerbations, and commonly described as prickling, deep aching, sharp, like an electric shock, and burning (13) with hyperalgesia and frequently allodynia upon examination (17).”
BackgroundInfluentialSelf-citationLauria, G., Hsieh, S. T., Johansson, O., Kennedy, W. R., Leger, J. M., Mellgren, S. I., Nolano, M., Merkies, I. S. J., Polydefkis, M., Smith, A. G., et al. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.03023.x · Cited by 864
Self-citationSima, A. A. F., Thomas, P. K., Ishii, D., & Vinik, A. (1997) · Diabetologia · doi:10.1007/bf03168192 · Cited by 822
Self-citation
Research works printed but not linked: 1
- Appell, 1991, DM and Other Peripheral Neuropathies Affecting Lower Urinary Tract Function, 365
Cited by
Items 701–800 of 1,002
Ismail, C. A. N., Aziz, C. B. A., Suppıan, R., & Long, I. (2018) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-018-0350-x · Cited by 28
Expression of pathogenic SCN9A mutations in the zebrafish: A model to study small-fiber neuropathy
Eijkenboom, I., Sopacua, M., Otten, A. B. C., Gerrits, M. M., Hoeijmakers, J. G. J., Waxman, S. G., Lombardi, R., Lauria, G., Merkies, I. S. J., Smeets, H. J. M., et al. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.10.008 · Cited by 34
Self-citationZhang, Y., Shen, X., He, L., Zhao, F., & Yan, S. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108096 · Cited by 31
Zhang, Z., Ma, Y., Fu, L., Li, L., Liu, J., Peng, H., & Jiang, H. (2020) · Journal of Diabetes Research · doi:10.1155/2020/5316769 · Cited by 31
“Diabetic autonomic neuropathy (DAN) is one of the most common chronic complications of diabetes, which may a ff ect cardiovascular, gastrointestinal, urogenital, and sudomotor function [1].”
Ferdousi, M., Azmi, S., Kalteniece, A., Petropoulos, I. N., Ponirakis, G., Asghar, O., Alam, U., Marshall, A. G., Boulton, A. J. M., Efron, N., et al. (2021) · European Journal of Neurology · doi:10.1111/ene.14757 · Cited by 30
“[7] Given that painful diabetic neuropathy is considered to arise from dysfunction and damage to nociceptive C- fibres and autonomic fibres,[8,9] it is no surprise that standard neurophysiology does not differentiate diabetic patients with painful compared to painless neuropathy.[10] Indeed, whilst neurophysiological…”
BackgroundSelf-citationThe Predictors of Painful Diabetic Neuropathy and Its Effect on Quality of Life
Çevik, A. B., & Olgun, N. (2021) · Pain Management Nursing · doi:10.1016/j.pmn.2021.04.002 · Cited by 30
Khan, I., Kumari, P., Kumar, R., Khatri, D. K., & Singh, S. B. (2022) · Archives of Physiology and Biochemistry · doi:10.1080/13813455.2022.2108454 · Cited by 33
“…to the defective insulin secretion by pancreatic b -cells or the inability of insulin-sensitive tissues to respond to insulin, which leads to a higher level of blood glucose resulting in metabolic and vascular complications (Tesfaye et al. 2010, Galicia-Garcia et al. 2020, Ogurtsova et al. 2022).”
Røikjer, J., Croosu, S. S., Frøkjær, J. B., Hansen, T. M., Arendt‐Nielsen, L., Ejskjær, N., & Mørch, C. D. (2022) · Pain · doi:10.1097/j.pain.0000000000002780 · Cited by 28
Autonomic Test by EZSCAN in the Screening for Prediabetes and Diabetes
Yang, Z., Xu, B., Lu, J., Tian, X., Li, M., Sun, K., Huang, F., Liu, Y., Xu, M., Bi, Y., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0056480 · Cited by 29
Little, S. A., Chadwick, T. J., Choudhary, P., Brennand, C., Stickland, J., Barendse, S., Olateju, T., Leelarathna, L., Walkinshaw, E., Tan, H. K., et al. (2012) · BMC Endocrine Disorders · doi:10.1186/1472-6823-12-33 · Cited by 34
Ponirakis, G., Fadavi, H., Petropoulos, I. N., Azmi, S., Ferdousi, M., Dabbah, M. A., Kheyami, A., Alam, U., Asghar, O., Marshall, A. G., et al. (2015) · Journal of Diabetes Research · doi:10.1155/2015/847854 · Cited by 29
“The Toronto Diabetic Neuropathy Expert group recommendation was followed to define DPN: (a) abnormal PMNCV (<42m/s) and (b) abnormal symptoms or signs of neuropathy, NDS (>2) [23].”
MethodSelf-citationDevelopment of a Novel Technique to Measure Corneal Nerve Migration Rate
Edwards, K. P., Pritchard, N., Poole, C. M., Dehghani, C., Rashah, K. A., Russell, A. W., Malik, R. A., & Efron, N. (2016) · Cornea · doi:10.1097/ico.0000000000000790 · Cited by 29
Self-citationSilva, T. P., Rolim, L. C., Filho, C. S., Zimmermann, L. M., Malerbi, F. K., & Dib, S. A. (2016) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2830 · Cited by 28
Scarr, D., Lovblom, L. E., Ostrovski, I., Kelly, D., Wu, T., Farooqi, M. A., Halpern, E. M., Ngo, M., Ng, E., Orszag, A., et al. (2016) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2016.07.024 · Cited by 28
Is electrodiagnosic testing for polyneuropathy overutilized?
Bodofsky, E. B., Carter, G. T., & England, J. D. (2016) · Muscle & Nerve · doi:10.1002/mus.25464 · Cited by 28
“more restrictive than the criteria used in most of the other studies.(18) Therefore, it is possible that the”
Diabetic Peripheral Neuropathy: Epidemiology, Physiopathology, Diagnosis and Treatment
Akter, N. (2019) · Delta Medical College Journal · doi:10.3329/dmcj.v7i1.40619 · Cited by 37
The role of biofactors in the prevention and treatment of age‐related diseases
Frank, J., Kisters, K., Stirban, O. A., Obeid, R., Lorkowski, S., Wallert, M., Egert, S., Podszun, M. C., Eckert, G. P., Pettersen, J. A., et al. (2021) · BioFactors · doi:10.1002/biof.1728 · Cited by 30
Ziegler, D., Παπάνας, Ν., Rathmann, W., Heier, M., Scheer, M., Meisinger, C., & KORA Study Group (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2340 · Cited by 28
Epidermal nerve fibers: Confidence intervals and continuous measures with nerve conduction
Engelstad, J. K., Taylor, S. W., Witt, L. V., Hoebing, B. J., Herrmann, D. N., Dyck, P. J. B., Klein, C. J., Johnson, D. M., Davies, J. L., Carter, R. E., et al. (2012) · Neurology · doi:10.1212/wnl.0b013e3182759608 · Cited by 28
Self-citationDisproportionate pupillary involvement in diabetic autonomic neuropathy
Yuan, D., Spaeth, E. B., Vernino, S. A., & Muppidi, S. (2014) · Clinical Autonomic Research · doi:10.1007/s10286-014-0258-6 · Cited by 27
Teleneurology clinics for polyneuropathy: a pilot study
Wilson, A. M., Jamal, N. I., Cheng, E. M., Inkelas, M., Saliba, D., Hanssen, A., Torres, J. A., & Ong, M. K. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09553-0 · Cited by 27
Okdahl, T., Brock, C., Fløyel, T., Wegeberg, A., Jakobsen, P. E., Ejskjær, N., Pociot, F., Brock, B., & Størling, J. (2020) · Clinical Endocrinology · doi:10.1111/cen.14261 · Cited by 30
Haque, F., Reaz, M. B. I., Ali, S. H. M., Arsad, N., & Chowdhury, M. E. H. (2020) · Scientific Reports · doi:10.1038/s41598-020-78787-0 · Cited by 27
Prediction of cardiac autonomic neuropathy using a machine learning model in patients with diabetes
Abdalrada, A. S., Abawajy, J., Al‐Quraishi, T., & Islam, S. M. S. (2022) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188221086693 · Cited by 32
“23 There is, however, still debate about the diagnostic criteria and staging of CAN using Ewing’s test.”
MethodIshibashi, F., Kosaka, A., & Tavakoli, M. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.864332 · Cited by 29
Diabetic neuropathy: Past, present, and future.
Aldave, J. E. Q., Durand‐Vásquez, M. D. C., Osorio, E. R. G., Suárez-Rojas, J., Roseboom, P. J., Alcalá‐Mendoza, R. M., Arroyo, J., Zavaleta‐Gutiérrez, F. E., Urteaga, L. A. C., & Concepción‐Zavaleta, M. J. (2023) · PubMed Central · doi:10.22088/cjim.14.2.153 · Cited by 47
“bladder capacity, and urinary retention (88, 95).”
BackgroundGajos, G., Konieczyńska, M., Zalewski, J., & Undas, A. (2015) · Cardiovascular Diabetology · doi:10.1186/s12933-015-0207-2 · Cited by 27
Ulnar entrapment neuropathy in patients with type 2 diabetes mellitus: An electrodiagnostic study
Rota, E., Zavaroni, D., Parietti, L., Iafelice, I., Mitri, P. D., Terlizzi, E., Morelli, N., Immovilli, P., & Guidetti, D. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2014.01.024 · Cited by 27
Maser, R. E., Lenhard, M. J., Peters, M. B., Irgau, I., & Wynn, G. M. (2011) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2011.11.014 · Cited by 32
Barrado, F. G., Kuypers, D. R. J., & Matricali, G. A. (2015) · Clinical Transplantation · doi:10.1111/ctr.12572 · Cited by 27
“Diabetic neuropathy is caused by chronic hyperglycemia and microvascular disease, the first leading to nerve injury through osmotic changes and the latter through ischemia (3).”
BackgroundDavies, B. R., Cramp, F. L., Gauntlett‐Gilbert, J., Wynick, D., & McCabe, C. (2015) · Physiotherapy · doi:10.1016/j.physio.2015.04.003 · Cited by 32
Rajan, R. S., de Gray, L., & George, E. (2013) · Continuing Education in Anaesthesia Critical Care & Pain · doi:10.1093/bjaceaccp/mkt063 · Cited by 28
Moon, J.-S., Clark, V. M., Beabout, J. W., Swee, R. G., & Dyck, P. J. (2011) · Archives of Neurology · doi:10.1001/archneurol.2011.211 · Cited by 31
He, T., Wang, C., Zuo, A., Liu, P., Zhao, R., Li, W., Chen, L., & Hou, X. (2017) · Journal of Diabetes Research · doi:10.1155/2017/8289740 · Cited by 27
Circulating levels of fibroblast growth factor 21 in early-stage diabetic kidney disease
Esteghamati, A., Khandan, A., Momeni, A., Behdadnia, A., Ghajar, A., Nikdad, M., Noshad, S., Nakhjavani, M., & Afarideh, M. (2017) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-017-1554-7 · Cited by 29
“Extensive details on the diagnosis of diabetic neuropathy are available elsewhere [11].”
BackgroundC-peptide is independent associated with diabetic peripheral neuropathy: a community-based study
Qiao, X., Zheng, H., Zhang, S., Liu, S., Xiong, Q., Mao, F., Zhang, Z., Wen, J., Ye, H., Li, Y., et al. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0208-2 · Cited by 28
“DPN was diagnosed according to the modified Toronto Expert Consensus [3] as follows: (1) non-DPN, all neurological symptoms/signs and NCV were normal; (2) clinical DPN, at least two abnormal results among neurological symptoms/signs, or ankle reflex in accordance with a distal symmetrical polyneuropathy and normal NCV…”
BackgroundMethodInfluentialWang, D., Wang, C., Duan, X., Yang, Z., Bai, Z., Hu, H., Yan, L., & Shen, J. (2017) · European Radiology · doi:10.1007/s00330-017-5043-1 · Cited by 27
“It has been recently defined as a symmetrical, length-dependent sensorimotor polyneuropathy [19].”
BackgroundDaniele, G., Winnier, D. A., Mari, A., Bruder, J., Fourcaudot, M. J., Zuo, P., HANSIS-DIARTE, A. A., Jenkinson, C. P., Tripathy, D., & Folli, F. B. (2017) · Acta Diabetologica · doi:10.1007/s00592-017-1065-z · Cited by 31
Zalaket, J., Wehbe, T. W., & Jaoude, E. A. (2017) · Journal of Nutrition & Intermediary Metabolism · doi:10.1016/j.jnim.2017.12.001 · Cited by 29
Amara, F., Hafez, S., Orabi, A., Etriby, A. E., Rahim, A. A. A., Zakaria, E., Koura, F., Talaat, F., Gawish, H., Attia, I., et al. (2019) · Current Diabetes Reviews · doi:10.2174/1573399815666190226150402 · Cited by 27
Vitamin B12 Deficiency and Foot Ulcers in Type 2 Diabetes Mellitus: A Case–Control Study
Badedi, M., Darraj, H. A., Hummadi, A. A., Solan, Y., Zakri, I., Khawaji, A. A., Daghreeri, M., & Budaydi, A. (2019) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s233683 · Cited by 35
Huang, L., Zhang, Y., Wang, Y., Shen, X., & Yan, S. (2019) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2019.11.005 · Cited by 28
Gebrie, A., Tesfaye, B., & Sisay, M. (2020) · Heliyon · doi:10.1016/j.heliyon.2020.e05655 · Cited by 35
Ye, S., Cheng, Z., Zhuo, D., & Liu, S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25158126 · Cited by 34
“DSPN accounts for about 75% of DN and is the typical form of diabetic peripheral neuropathy (DPN) [4].”
BackgroundMurça, T. M., Almeida, T. C. S., Raizada, M. K., & Ferreira, A. J. (2012) · Experimental Physiology · doi:10.1113/expphysiol.2011.063461 · Cited by 26
“One of the most serious, prevalent and poorly understood complications of diabetes is diabetic autonomic neuropathy, which is widespread in the body and has an important impact on the quality of life and survival of diabetic patients (Kennedy et al. 1995; Edwards et al. 2008; Tesfaye et al. 2010).”
BackgroundParry, M. J. E., Danielson, K., Brennenstuhl, S., Drennan, I. R., & Morrison, L. J. (2017) · Resuscitation · doi:10.1016/j.resuscitation.2017.01.011 · Cited by 31
Herder, C., Kannenberg, J. M., Huth, C., Carstensen‐Kirberg, M., Rathmann, W., Köenig, W., Strom, A., Bönhof, G. J., Heier, M., Thorand, B., et al. (2018) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.3000 · Cited by 26
Kumar, N., Pop‐Busui, R., Musch, D. C., Reed, D. M., Momont, A. C., Hussain, M., Raval, N., Moroi, S. E., & Shtein, R. M. (2018) · Cornea · doi:10.1097/ico.0000000000001668 · Cited by 30
Factors affecting phantom limb pain in patients undergoing amputation: retrospective study
Noguchi, S., Saito, J., Nakai, K., Kitayama, M., & Hirota, K. (2019) · Journal of Anesthesia · doi:10.1007/s00540-018-2599-0 · Cited by 26
Clinical spectrum and diagnosis of diabetic neuropathies
Oh, J. (2020) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2020.202 · Cited by 33
“The generally accepted criteria are those of the expert panels at the International Symposium on Diabetic Neuropathy in Toronto, 2009 [17].”
BackgroundMethodBouché, P. (2020) · Revue Neurologique · doi:10.1016/j.neurol.2019.11.007 · Cited by 30
Mohiuddin, M., Pivetta, B., Gilron, I., & Khan, J. S. (2021) · Pain Medicine · doi:10.1093/pm/pnab042 · Cited by 28
Corneal confocal microscopy differentiates inflammatory from diabetic neuropathy
Fleischer, M., Lee, I., Erdlenbruch, F., Hinrichs, L., Petropoulos, I. N., Malik, R. A., Hartung, H., Kieseier, B. C., Kleinschnitz, C., & Stettner, M. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-021-02130-1 · Cited by 26
“Nerve conduction studies (NCS) were undertaken and diabetic neuropathy was defined according to the Toronto consensus, which requires the presence of symptoms (abnormal NSP) or signs of neuropathy (NDS > 2) and abnormal peroneal nerve conduction velocity (PMNCV < 40 m/s) and the patients were subdivided into those wit…”
MethodSelf-citationGaliero, R., Ricciardi, D., Pafundi, P. C., Todisco, V., Tedeschi, G., Cirillo, G., & Sasso, F. C. (2021) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2021.108856 · Cited by 26
Huang, L., Wu, P., Zhang, Y., Lin, Y., Shen, X., Zhao, F., & Yan, S. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13763 · Cited by 29
Bönhof, G. J., Strom, A., Apostolopoulou, M., Karusheva, Y., Sarabhai, T., Pesta, D. H., Roden, M., & Ziegler, D. (2022) · Diabetologia · doi:10.1007/s00125-022-05674-w · Cited by 27
Badian, R. A., Ekman, L., Pripp, A. H., Utheim, T. P., Englund, E. M., Dahlin, L. B., Rolandsson, O., & Lagali, N. (2023) · Diabetes · doi:10.2337/db22-0863 · Cited by 28
Metformin-Induced Vitamin B12 Deficiency in Patients With Type-2 Diabetes Mellitus
Tiwari, A., Singh, R. K., Satone, P. D., & Meshram, R. J. (2023) · Cureus · doi:10.7759/cureus.47771 · Cited by 36
“According to reports, 14% to 30% people on long-term metformin have lower level of vitamin B12 in blood, and 30% develop vitamin B12 malabsorption [6].”
BackgroundTavakoli, M., Mitu-Pretorian, M., Petropoulos, I. N., Fadavi, H., Asghar, O., Alam, U., Ponirakis, G., Jeziorska, M., Marshall, A., Efron, N., et al. (2012) · Diabetes · doi:10.2337/db12-0574 · Cited by 247
Self-citationLados-Krupa, A., Konieczyńska, M., Chmiel, A., & Undas, A. (2015) · Journal of Diabetes Research · doi:10.1155/2015/456189 · Cited by 26
Raafat, K. M., & Omar, A. G. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1077463 · Cited by 28
“An important indicator for diabetic patients having peripheral neuropathy is the decline of peripheral nerve conduction (Said, 2007; Tesfaye et al., 2010; Widenfalk et al., 2009).”
BackgroundPeripheral neuropathy in the elderly
SUZUKI, M. T. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52902-2.00046-1 · Cited by 30
mTORC1-Independent Reduction of Retinal Protein Synthesis in Type 1 Diabetes
Fort, P. E., Losiewicz, M. K., Pennathur, S., Jefferson, L. S., Kimball, S. R., Abcouwer, S. F., & Gardner, T. W. (2014) · Diabetes · doi:10.2337/db14-0235 · Cited by 27
Rivera, A. L., Estañol, B., Fossión, R., Toledo-Roy, J. C., Callejas-Rojas, J. A., Gien-López, J. A., Delgado‐García, G. R., & Frank, A. (2016) · PLoS ONE · doi:10.1371/journal.pone.0165904 · Cited by 27
Hjortkjær, H. Ø., Jensen, T. J., Kofoed, K. F., Mogensen, U. M., Sigvardsen, P. E., Køber, L., Hilsted, K. L., Corinth, H., Theilade, S., & Hilsted, J. (2016) · BMJ Open · doi:10.1136/bmjopen-2016-012307 · Cited by 27
Temporal changes in the exercise pressor reflex in type 1 diabetic rats
Grotle, A., Garcia, E. A., Huo, Y., & Stone, A. J. (2017) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00399.2017 · Cited by 26
Yamada, E., Namiki, Y., Takano, Y., Takamine, H., Inazumi, K., Sasaki, H., Yamada, M., Ito, S., Iwasaki, T., Mantani, N., et al. (2017) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.14022 · Cited by 26
Park, J. H., & Won, J. C. (2018) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2018.0068 · Cited by 26
Hansen, T. M., Brock, B., Juhl, A. H., Drewes, A. M., Vorum, H., Andersen, C. U., Jakobsen, P. E., Karmisholt, J., Frøkjær, J. B., & Brock, C. (2019) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2018.12.016 · Cited by 26
Relationship between diabetic neuropathy and sarcopenia
Özgür, Y., Akın, S., & Özcan, K. (2019) · Primary care diabetes · doi:10.1016/j.pcd.2019.04.007 · Cited by 26
Kim, S. H., Park, T. S., & Jin, H. Y. (2020) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2019.0190 · Cited by 26
Diabetic Cardiac Autonomic Neuropathy
Serhiyenko, V. A., & Serhiyenko, A. A. (2023) · Springer eBooks · doi:10.1007/978-3-031-25519-9_57 · Cited by 26
Genetic Studies on Diabetic Microvascular Complications: Focusing on Genome-Wide Association Studies
Kwak, S. H., & Park, K. S. (2015) · Endocrinology and Metabolism · doi:10.3803/enm.2015.30.2.147 · Cited by 26
Chung, J. O., Cho, D. H., Chung, D. J., & Chung, M. Y. (2013) · Diabetic Medicine · doi:10.1111/dme.12338 · Cited by 25
Li, Y., Ma, W., Xie, C., Zhang, M., Yin, X., Wang, F., Xu, J., & Shi, B. (2016) · Medicine · doi:10.1097/md.0000000000005443 · Cited by 28
NerveCheck for the Detection of Sensory Loss and Neuropathic Pain in Diabetes
Ponirakis, G., Odriozola, M. N., Odriozola, S., Petropoulos, I. N., Azmi, S., Ferdousi, M., Fadavi, H., Alam, U., Marshall, A. G., Jeziorska, M., et al. (2016) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2016.0279 · Cited by 26
“Indeed neuropathy is central to the development of painful neuropathy and foot ulceration in patients with diabetes.(4,5) Hence, it is important to identify early sensory deficits in patients with diabetes to improve the risk factors and limit the development and progression of DPN.”
BackgroundSelf-citationXu, L., Lin, X., Guan, M., & Liu, Y. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0519-9 · Cited by 26
Central and Peripheral Mechanisms in ApoE4-Driven Diabetic Pathology
Koren-Iton, A., Salomon‐Zimri, S., Smolar, A., Stein, E. S., Dori, A., Chapman, J., & Michaelson, D. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21041289 · Cited by 28
“late complication of diabetes, defined as a symmetric length-dependent sensorimotor polyneuropathy attributable to metabolic and microvascular alterations as a result of chronic hyperglycemia exposure (diabetes) [36,37].”
Erdem, S., Karahan, M., Ava, S., Pekkolay, Z., Demirtaş, A. A., & Keklíkçí, U. (2020) · International Ophthalmology · doi:10.1007/s10792-020-01499-x · Cited by 26
Roy, S., Kant, R., Kumar, B., Khapre, M. P., & Bairwa, M. C. (2020) · Diabetes and Vascular Disease Research · doi:10.1177/1479164120944134 · Cited by 25
A Systematic Review of the Diagnostic Methods of Small Fiber Neuropathies in Rehabilitation
Chiaramonte, R., Romano, M., & Vecchio, M. (2020) · Diagnostics · doi:10.3390/diagnostics10090613 · Cited by 25
“The tests include cold and arm detection threshold (WDT), cold and warm pain threshold, paradoxical heat sensation, allodynia, and vibration detection threshold.”
MethodInfluentialKersebaum, D., Fabig, S., Sendel, M., Sachau, J., Lassen, J., Rehm, S., Hüllemann, P., Baron, R., & Gierthmühlen, J. (2020) · PAIN Reports · doi:10.1097/pr9.0000000000000858 · Cited by 28
“All contacted patients had probable (presence of a combination of symptoms and signs of neuropathy including any 2 ormore of the following: neuropathic symptoms, decreased distal sensation, or unequivocally decreased or absent ankle reflexes) or confirmed (presence of an abnormality of nerve conduction or validatedmea…”
MethodJasmine, A., Venguidesvarane, A. G., Durai, V., Anitha Rani, M., Shriraam, V., Samya, V., Gayathri, T., & Mahadevan, S. (2020) · International Journal of Diabetes in Developing Countries · doi:10.1007/s13410-020-00885-6 · Cited by 40
“Besides, several studies have shown that neuropathic symptoms can improve with optimization of blood sugar control and avoidance of extreme blood glucose fluctuations before any severe morbidity sets in [8].”
BackgroundGholami, F., Khaki, R., Mirzaei, B., & Howatson, G. (2021) · Experimental Gerontology · doi:10.1016/j.exger.2021.111481 · Cited by 26
Granovsky, Y., Topaz, L. S., Laycock, H. C., Zubiedat, R., Crystal, S., Buxbaum, C., Bosak, N., Hadad, R., Domany, E., Khamaisi, M., et al. (2021) · Pain · doi:10.1097/j.pain.0000000000002434 · Cited by 30
Rasmussen, V. F., Jensen, T. S., Tankişi, H., Karlsson, P., Vestergaard, E. T., Kristensen, K., Nyengaard, J. R., & Terkelsen, A. J. (2021) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2021.108027 · Cited by 26
Khan, K. S., Overgaard, K., Tankişi, H., Karlsson, P., Devantier, L., Gregersen, S., Jensen, T. S., Finnerup, N. B., Pop-Busui, R., Dalgas, U., et al. (2022) · Diabetologia · doi:10.1007/s00125-021-05646-6 · Cited by 34
“Individuals were assigned to the DPN group according to the Toronto criteria of confirmed neuropathy [22].”
MethodEiki, N., Maake, M. M. S., Lebelo, S. L., Sakong, B. M., Sebola, N. A., & Mabelebele, M. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.762771 · Cited by 25
“The outcomes of the study revealed that most respondents had a lower level of education, supporting the idea that less educated people are less acculturated and hence have a greater understanding of conventional remedies (15).”
BackgroundDeep breathing improves blunted baroreflex sensitivity even after 30 years of type 1 diabetes
the FinnDiane Study Group, Rosengård‐Bärlund, M., Bernardi, L., Holmqvist, J., Debarbieri, G., Mäntysaari, M., af Björkesten, C.-G., Forsblom, C. M., & Groop, P. (2011) · Diabetologia · doi:10.1007/s00125-011-2164-y · Cited by 25
“This methodology conforms to the most recent consensus statement on diabetic neuropathy [22].”
Self-citationYang, X., Liu, F., Guo, J., Yao, W., Qingqin, L., Liu, T., & Xu, L. (2015) · BMC Complementary and Alternative Medicine · doi:10.1186/s12906-015-0600-0 · Cited by 26
“DPN is manifested by MNCV and SNCV deficits as well as by thermal perception thresholds [20].”
BackgroundKarlsson, P., Porretta‐Serapiglia, C., Lombardi, R., Jensen, T. S., & Lauria, G. (2013) · Journal of the Peripheral Nervous System · doi:10.1111/jns5.12007 · Cited by 25
“Moreover, patients with painful symptoms showing large axonal swellings but normal density of IENF cannot be diagnosed with SFN following currently accepted criteria (Tesfaye et al., 2010).”
BackgroundInfluentialSelf-citationdo Nascimento, P. S., Lovatel, G. A., Barbosa, S., Ilha, J., Centenaro, L. A., Malysz, T., Xavier, L. L., Schaan, B. D., & Achaval, M. (2011) · Brain Research · doi:10.1016/j.brainres.2011.01.063 · Cited by 29
Update on the American Diabetes Association Standards of Medical Care
Zitkus, B. S. (2014) · The Nurse Practitioner · doi:10.1097/01.npr.0000451880.48790.50 · Cited by 30
Kamo, A., Tominaga, M., Kamata, Y., Kaneda, K., Ko, K. C., Matsuda, H., Kimura, U., Ogawa, H., & Takamori, K. (2014) · Journal of Investigative Dermatology · doi:10.1038/jid.2014.256 · Cited by 25
“Alterations in intraepidermal nerve density are likely associated with the severity of neuropathy in patients with diabetes (Tesfaye et al., 2010).”
BackgroundSkin biopsy in painful and immune‐mediated neuropathies
Lauria, G., & Lombardi, R. (2012) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2012.00430.x · Cited by 27
“The loss of IENF can be reliably measured and is currently used to diagnose small fiber neuropathy (SFN), a condition defined by the absence of clinical and neurophysiological evidence of large fiber involvement (Tesfaye et al., 2010).”
BackgroundSelf-citationThe Quest for more Research on Painful Diabetic Neuropathy
Nawroth, P. P., Bendszus, M., Pham, M., Jende, J. M. E., Heiland, S., Ries, S. R., Schumann, C., Schmelz, M., Schuh‐Hofer, S., Treede, R., et al. (2017) · Neuroscience · doi:10.1016/j.neuroscience.2017.09.023 · Cited by 28
Gondim, F. D. A. A., Barreira, A. A., Claudino, R., Waddington‐Cruz, M., da Cunha, F. M. B., de Freitas, M. R., França, M. C., Gonçalves, M. V. M., Marques, W., Nascimento, O. J. M., et al. (2018) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x20180015 · Cited by 30
Visceral Adiposity Index was a useful Predictor of Prediabetes
Gu, D., Ding, Y., Zhao, Y., & Qu, Q. (2017) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0043-120440 · Cited by 29
Latini, A., Borgiani, P., Benedittis, G. D., D’Amato, C., Greco, C., Lauro, D., Novelli, G., Spallone, V., & Ciccacci, C. (2020) · DNA and Cell Biology · doi:10.1089/dna.2019.5326 · Cited by 26
“The DN is heterogeneous in terms of clinical manifestations, pattern of neurological involvement, pathological alterations, and underlying mechanisms (Tesfaye et al. , 2010).”
Self-citationXue, P., Covassin, N., Ran, X., Zhou, J., Zhang, X., Yan, D., Li, X., Gao, Y., & Tang, X. (2020) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2020.108484 · Cited by 27
Metadata
- Authors
- Tesfaye, S., Boulton, A. J. M., Dyck, P. J., Freeman, R., Horowitz, M., Kempler, P., Lauria, G., Malik, R. A., Spallone, V., Vinik, A., Bernardi, L., Valensi, P., & on behalf of the Toronto Diabetic Neuropathy Expert Group
- Affiliations
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- University of Manchester (GB)
- Mayo Clinic (US)
- Beth Israel Deaconess Medical Center (US)
- The University of Adelaide (AU)
- I Department of Medicine, Semmelweis University, Budapest, Hungary;
- Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)
- University of Rome Tor Vergata (IT)
- Eastern Virginia Medical School (US)
- University of Pavia (IT)
- Assistance Publique – Hôpitaux de Paris (FR)
- Corresponding author
- Tesfaye, Solomon
- ORCID
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2010-10-01
- Volume
- 33
- Issue
- 10
- Pages
- 2285-2293
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2945176
- OpenAlex
- W2113384757
- Cited by
- 2,690
- References
- 77
- Citations by year
- 2026: 180 · 2025: 190 · 2024: 221 · 2023: 199 · 2022: 226 · 2021: 235 · 2020: 220 · 2019: 175 · 2018: 189 · 2017: 155 · 2016: 157 · 2015: 127 · 2014: 151 · 2013: 102 · 2012: 94
- FWCI
- 8.09
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- SZTE Publicatio Repozitórium (University of Szeged) (acceptedVersion, other-oa)
- Archivio Istituzionale della Ricerca (Universita Degli Studi Di Milano) (submittedVersion, cc-by-nc-nd)
- Cineca Institutional Research Information System (Tor Vergata University) (submittedVersion, cc-by-nc-nd)
- Adelaide Research & Scholarship (AR&S) (University of Adelaide) (submittedVersion, cc-by-nc-nd)
- Research Explorer (The University of Manchester) (submittedVersion)
- University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
- Funders
- Eli Lilly and Company
- Louisiana State University
- Eastern Virginia Medical School
- Semmelweis Egyetem
- Gentofte Hospital
- University of Toronto
- Odense Universitetshospital
- Szegedi Tudományegyetem
- Leibniz-Gemeinschaft
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Oncology › Cancer Treatment and Pharmacology
- Keywords
- diabetic neuropathy, diabetic peripheral neuropathy, diabetic autonomic neuropathy, diabetic neuropathic pain, neuropathy classification, diagnostic criteria, neuropathy treatment
- MeSH terms
- Diabetic Neuropathies, Humans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.